LINC02500

Across TCGA pan-cancer cohorts, LINC02500 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC02500’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where LINC02500 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02500 is over-expressed in tumor, although a few such as STAD and COAD show the opposite, repressed pattern.

STAD and COAD are the cancer types where LINC02500 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02500 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	−0.148	.002	8	view →
COAD	All	All	−0.082	.002	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

LINC02500–STAD

Open the STAD breakdown →